Abstract:Pentavalent vanadium (V5) as Na48VO3 was given i.p. to male Wistar rats at a dose of 5 mumol/kg in order to study its organ distribution pattern. Two days after injection, kidneys reached a V level of about 28 nmol/g wet weight, followed in decreasing order by spleen, liver, bone, blood plasma, testis, lung, erythrocytes and brain in control rats. A similar distribution pattern was seen after injection of tetravalent vanadium (V4) given as 48VOSO4. Two chelators, desferrioxamine B (Desferal) or Ca-Na3-diethylene triamine pentaacetic acid (DTPA), were given i.p. 24 h after the vanadium injections to different groups of rats at two dosage levels, 30 and 100 mumol/kg. Desferal (30 mumol/kg) reduced the vanadium content of the kidney by 17%, of the liver by 0%, and of the lung by 7%. The corresponding figures for the effect of DTPA (30 mumol/kg) were 7%, plus 15%, and 0%, respectively. At 100 mumol/kg, Desferal reduced the same organ levels by 20%, 26%, and 25%, respectively, and DTPA by 9%, 18%, and 25%, respectively. Both chelators raised faecal excretion at the low level, and both urinary and faecal excretion at the high level. Spleen and bone seemed to bind vanadium to a higher degree than the other organs under examination. Human erythrocytes, when incubated with 48VOSO4 (V4) or Na48VO3 (V5), were found to accumulate nearly the double amount of V5 as compared to V4. Glutathione (GSH) which is the main reducing substance within the erythrocytes, reduced the uptake of V5 to the V4 level when incubated together with GSH before addition to the cell suspension. Pretreating the erythrocytes with diethyl-maleate (DEM) which blocks the reducing SH groups of intracellular GSH, also reduced the uptake of V5. This may indicate a GSH dependent reduction of V5 to V4 within the erythrocytes. Four chelators, among them Desferal and DTPA, were found to reduce the cellbound amount of vanadium, either by extracting vanadium as V4, or by inhibiting uptake by the red blood cells.

Membrane transport of vanadium compounds and the interaction with the erythrocyte membrane

The Permeability and Cytotoxicity of Insulin-Mimetic Vanadium Compounds

The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes.

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

Vanadium stimulates mitochondrial ROS production in different ways

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Binding of Vanadium Compounds Perturbs Conformation and Aggregation State of Insulin

Comparison of Intestinal Absorption of Two Insulin-Mimic Vanadyl Complexes Using Caco-2 Monolayers As Model System

Binding of vanadate to human erythrocyte ghosts and subsequent events

Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization

Permeation of Vanadium(iii, IV, V)-dipicolinate Complexes Across MDCK Cell Monolayer and Comparison with Caco-2 Cells

Effect of the Chloro-Substitution on Lowering Diabetic Hyperglycemia of Vanadium Complexes with Their Permeability and Cytotoxicity.

Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress.

Chemical, biochemical, and biological behaviors of vanadate and its oligomers.

Spectroscopic and DFT Study on the Interaction System of Vanadium with L-Proline in Aqueous Solution

Pharmacodynamics and Pharmacokinetics of the Insulin-Mimetic Agent Vanadyl Acetylacetonate in Non-Diabetic and Diabetic Rats.

Novel vanadyl complexes of alginate saccharides: synthesis, characterization, and biological activities

Solution chemistry of oxidovanadium(IV) complexes with two bis-kojic acid derivatives

The effect of chelating agents on vanadium distribution in the rat body and on uptake by human erythrocytes

Cytotoxicity of vanadium dioxide nanoparticles to human embryonic kidney cell line: Compared with vanadium(IV/V) ions